Search Results - "Hettler, Dominique"
-
1
Randomized, double-blind, placebo-controlled, pilot trial of high-dose methylprednisolone in aneurysmal subarachnoid hemorrhage
Published in Journal of neurosurgery (01-03-2010)“…The object of this study was to determine the efficacy of methylprednisolone in reducing symptomatic vasospasm and poor outcomes after subarachnoid hemorrhage…”
Get full text
Journal Article -
2
Preliminary guidelines for the detection and management of drug-related problems in cancer patients with type 2 diabetes mellitus: a practical resource for oncology pharmacists
Published in Supportive care in cancer (01-12-2024)“…Purpose The prevalence of type 2 diabetes mellitus (T2DM) in cancer patients is high. During the medication review process, clinical pharmacists could detect…”
Get full text
Journal Article -
3
Cannabidiol–drug interaction in cancer patients: A retrospective study in a real‐life setting
Published in British journal of clinical pharmacology (01-07-2023)“…Cannabidiol (CBD) consumption in cancer patients is growing and there is a need to investigate how to detect cannabidiol–drug interactions (CDIs). However,…”
Get full text
Journal Article -
4
Predictive factors for clinically significant pharmacist interventions at hospital admission
Published in Medicine (Baltimore) (01-03-2018)“…Pharmaceutical care activities at hospital admission have a significant impact on patient safety. The objective of this study was to identify predictive…”
Get full text
Journal Article -
5
Intravenous and subcutaneous immunoglobulins-associated eczematous reactions occur with a broad range of immunoglobulin types: A French national multicenter study
Published in Journal of the American Academy of Dermatology (01-02-2023)“…Human immunoglobulins are used for treating diverse inflammatory and autoimmune disorders. Eczema is an adverse event reported but poorly described. To…”
Get full text
Journal Article -
6
Association between proton pump inhibitors and severe hematological toxicity in patients receiving pemetrexed-based anticancer treatment: The prospective IPPEM study
Published in Lung cancer (Amsterdam, Netherlands) (01-04-2022)“…•Hematological toxicity of pemetrexed is more severe with PPI use.•Clinical consequences of pemetrexed toxicity are more frequent with PPI use.•When starting…”
Get full text
Journal Article -
7
Development and validation of a ready-to-use score to prioritise medication reconciliation at patient admission in an orthopaedic and trauma department
Published in European journal of hospital pharmacy. Science and practice (01-09-2022)“…ObjectiveMedication reconciliation (MR) is recognised as an important tool in preventing medication errors such as unintentional discrepancies (UDs). The aim…”
Get full text
Journal Article -
8
Prevalence of cannabidiol (CBD) consumption and cancer patients’ expectations in one oncology day-hospital: A cross-sectional study and questionnaire validation
Published in Journal of oncology pharmacy practice (12-07-2023)“…Introduction The growing interest of cannabidiol (CBD) in medical care prompted French health authorities to explore the potential of CBD in cancer-related…”
Get full text
Journal Article -
9
Venous thromboembolism: What pharmacists know? What do they need?
Published in Journal of clinical oncology (01-11-2014)“…Abstract only 212 Background: Venous thromboembolism is frequent in cancer. Low molecular weight heparins (LMWH) are recommended for prevention/treatment of…”
Get full text
Journal Article -
10
Randomized, double-blind, placebo-controlled, pilot trial of high-dose methylprednisolone in aneurysmal subarachnoid hemorrhage: Clinical article
Published in Journal of neurosurgery (01-03-2010)“…Object The object of this study was to determine the efficacy of methylprednisolone in reducing symptomatic vasospasm and poor outcomes after subarachnoid…”
Get full text
Journal Article -
11
Venous thromboembolism: What pharmacists know? What do they need?
Published in Journal of oncology pharmacy practice (01-02-2016)“…Introduction Venous thromboembolism is common in cancer. Low-molecular weight heparins are recommended for prolonged treatment (3–6 months or more if the…”
Get full text
Journal Article -
12
Prise en charge de la maladie thromboembolique (MTEV) à l'officine: état des lieux en Champagne-Ardenne
Published in Journal de pharmacie clinique (2014)Get full text
Journal Article